3 FTSE Dividends Lifted This Week: Hargreaves Lansdown PLC, Dechra Pharmaceuticals plc And Staffline Group Plc

Hargeaves Lansdown PLC (LSE: HL), Dechra Pharmaceuticals plc (LON: DPH) and Staffline Group Plc (LON: STAF) raise their payments.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 (FTSEINDICES: ^FTSE) is limping along today, up 9 points to 6,523 by late morning. With the focus on US jobs data, due later today, the index of top UK stocks looks set to end its four-week losing streak, standing 110 points up on the week so far.

But even in bearish times, dividends can keep shareholders going until the bulls return, and the FTSE is offering a decent 3.2% average forward yield these days. Here are there companies from the various indices that have lifted their dividends this week:

Dechra Pharmaceuticals

Dechra Pharmaceuticals (LSE: DPH) released a decent set of  final results on Tuesday, reporting a year of restructuring, with chief executive Ian Page saying of the outcome that “Dechra is now entirely focused on developing, manufacturing and marketing high margin, cash generative specialist veterinary pharmaceuticals and related products for global markets“.

With the firm’s underlying earnings per share (EPS) up 20% to 38.7p, the board saw fit to propose a final dividend of 9.66p per share to take the full-year payment up 14% to 14p per share. On a share price of 698p, that’s a relatively low yield of 2%, but the dividend has been rising steadily year-on-year.

Hargreaves Lansdown

Wednesday brought full-year results from Hargreaves Lansdown (LSE: HL), resulting in a final dividend of 14.38p per share plus a special dividend of 8.91p per share. Added to the interim payment, that gave a 31% lift to the firm’s total dividend to 29.59p per share. On today’s share price of 1,025p, it provides a modest yield of 2.9%, but we have seen earnings and dividends rising strongly over the past few years.

And with total assets under administration up 38% to £36.4bn and pre-tax profit up 28% to £195.2m, there may be quite a bit more to come. Analysts are currently forecasting a 14% rise in EPS next year, though that does put the shares on a fairly lofty P/E of over 28.

Staffline

It was interim results time for recruitment firm Staffline Group (LSE: STAF) on Wednesday, and things looked pretty good, with revenues up 14% to £187.2m and underlying pre-tax profit up 32% to £4.9m. The company’s interim dividend was increased by 22.6% to 3.8p per share, which suggests the current consensus for a 9.5p total dividend might be a bit conservative — it would provide a yield of only 1.8%.

While dividends are always welcome, the big reward for Staffline shareholders this year has come in the form of a 150% share price rise. And at 578p, we’re still looking at an undemanding forward P/E of only around 13.5.

Finally, if you’re looking for top investment ideas, it could well pay to take a close look at what Neil Woodford is buying.

The ace investor, whose Invesco Perpetual High Income fund would have turned £10,000 into £193,000 since its launch in 1988, remains bullish on the Aerospace & Defence sector. If you want to learn more, check out the Fool’s latest examination of Mr Woodford’s holdings.

But hurry, because the report will be available for a limited period only. Click here to enjoy your copy today.

> Alan does not own any shares mentioned in this article.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Investing Articles

2 dirt cheap FTSE 100 and FTSE 250 growth shares to consider!

Looking for great growth and value shares right now? These FTSE 100 and FTSE 250 shares could offer the best…

Read more »

Investing Articles

No savings? I’d use the Warren Buffett method to target big passive income

This Fool looks at a couple of key elements of Warren Buffett's investing philosophy that he thinks can help him…

Read more »

Investing Articles

This FTSE 100 hidden gem is quietly taking things to the next level

After making it to the FTSE 100 index last year, Howden Joinery Group looks to be setting its sights on…

Read more »

Investing Articles

A £20k Stocks and Shares ISA put into a FTSE 250 tracker 10 years ago could be worth this much now

The idea of a Stocks and Shares ISA can scare a lot of people away. But here's a way to…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

What next for the Lloyds share price, after a 25% climb in 2024?

First-half results didn't do much to help the Lloyds Bank share price. What might the rest of the year and…

Read more »

Investing Articles

I’ve got my eye on this FTSE 250 company

The FTSE 250's full of opportunities for investors willing to do the search legwork, and I think I've found one…

Read more »

Investing Articles

This FTSE 250 stock has smashed Nvidia shares in 2024. Is it still worth me buying?

Flying under most investors' radars, this FTSE 250 stock has even outperformed the US chip maker year-to-date. Where will its…

Read more »

Investing Articles

£11k stashed away? I’d use it to target a £1,173 monthly passive income starting now

Harvey Jones reckons dividend-paying FTSE 100 shares are a great way to build a long-term passive income with minimal effort.

Read more »